Valuation: Caplin Point Laboratories Limited

Market Cap 199B 2.09B 1.81B 1.7B 1.55B 2.91B 2.96B 19.89B 7.79B 99.84B 7.85B 7.68B 333B P/E 2026
17.9x
P/E 2027 * 28x
Enterprise Value 199B 2.09B 1.81B 1.7B 1.55B 2.91B 2.96B 19.89B 7.79B 99.84B 7.85B 7.68B 333B EV / Sales 2026
5.23x
EV / Sales 2027 * 8.02x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.15%
1 day+0.08%
1 week+2.09%
Current month+4.35%
1 month+1.50%
3 months+41.58%
6 months+50.22%
Current year+42.52%
1 week 2,501.95
Extreme 2501.95
2,662.8
1 month 2,455
Extreme 2455
2,700
Current year 1,502.45
Extreme 1502.45
2,700
1 year 1,502.45
Extreme 1502.45
2,700
3 years 950
Extreme 950
2,700
5 years 575
Extreme 575
2,700
10 years 180
Extreme 180
2,700
Manager TitleAgeSince
Chief Executive Officer 71 2015-03-27
Director of Finance/CFO - 2016-02-18
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 2026-01-30
Chairman 73 2010-01-26
Director/Board Member - 2025-11-04
Change 5-day change 1-year change 3-year change Capi.($)
+0.08%+2.09%+24.45%+154.32% 2.09B
-0.12%-1.12%+20.74%+71.50% 48.92B
-3.62%+2.58%+53.86%+118.67% 41.53B
-0.32%+0.21%-2.78%+17.02% 12.43B
+6.43%+5.40%+24.64%+82.96% 11.7B
-0.19%-0.38%+30.98%+136.36% 9.09B
+1.95%+9.12%+25.38%+40.22% 7.4B
-1.26%+3.82%+38.69%-13.93% 7.15B
+1.10%+2.29%+11.06%+184.02% 6.66B
-1.22%+4.46%-25.04%+29.64% 5.95B
Average +0.29%+3,622.21%+20.20%+82.08% 15.29B
Weighted average by Cap. -0.52%+4,990.82%+27.64%+83.51%

Financials

2026 2027 *
Net sales 21.28B 223M 193M 181M 165M 311M 316M 2.12B 832M 10.65B 838M 819M 35.53B 24.88B 261M 226M 212M 193M 363M 369M 2.48B 972M 12.45B 979M 958M 41.55B
Net income 6.16B 64.61M 55.99M 52.41M 47.82M 89.99M 91.51M 615M 241M 3.08B 243M 237M 10.29B 7.13B 74.73M 64.76M 60.63M 55.32M 104M 106M 711M 279M 3.57B 281M 274M 11.9B
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
26-08-11 ₹2,624.15 +0.08% 4,811
26-08-10 ₹2,622.00 +1.82% 8,448
26-08-07 ₹2,575.05 -0.37% 1,898
26-08-06 ₹2,584.55 +1.62% 5,764
26-08-05 ₹2,543.25 -1.06% 1,565
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,624.15INR
Average target price
2,505.00INR
Spread / Average Target
-4.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 524742 Stock